Specific targeting of point mutations in EGFR L858R-positive lung cancer by CRISPR/Cas9.
Cheung AH, Chow C, Zhang J, Zhou Y, Huang T, Ng KC, Or TC, Yao YY, Dong Y, Fung JM, Xiong L, Chan AK, Lung WR, Kang W, To KF.
Cheung AH, et al. Among authors: or tc.
Lab Invest. 2018 Jul;98(7):968-976. doi: 10.1038/s41374-018-0056-1. Epub 2018 May 10.
Lab Invest. 2018.
PMID: 29748615
Free article.